Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma

NCT02100930 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: Anti-GD2 3F8 Monoclonal Antibody
DRUG: GM-CSF (granulocyte-macrophage colony-stimulating factor)
DRUG: oral isotretinoin

Sponsor

Memorial Sloan Kettering Cancer Center